Skip to content

Incyte INCY Return on equity

Return on equity at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
38.8%+7.3pp
Pfizer logo
PfizerPFE
10.6%
Gilead Sciences logo
Gilead SciencesGILD
43.2%+10.7pp
Johnson & Johnson logo
Johnson & JohnsonJNJ
26.4%-3.0pp
Amgen logo
AmgenAMGN
101.3%-4.4pp
Biogen logo
BiogenBIIB
8%-1.2pp

Other financials

Income statement

See full
Revenue$1.3B+20.9%
Gross profit$1.2B+19.2%
Operating income$301.1M+46.8%
Net income$303.3M+91.7%
EPS (diluted)$1.47+83.8%

Balance sheet

See full
Cash & equivalents$3.5B+78.2%
Total debt$39.4M-8.6%
Total equity$5.6B+53.3%
Total assets$7.3B+27.7%

Cash flow

See full
Operating cash flow$369.4M+38.8%
CapEx$1.6M-43.5%
Free cash flow$367.7M+39.7%

Valuation

See full
Market cap$19.78B+59.9%
Enterprise value$16.35B+55.9%
P/E13.8×-568×
P/S3.7×+0.9×

Profitability

See full
Gross margin92.5%-0.2pp
Operating margin30%+26.1pp
Net margin26.7%+26.2pp

Returns & leverage

See full
Debt / equity0.0×
Current ratio3.7×+1.6×

Where this comes from

Calculated from Incyte’s reported figures.

Based on trailing twelve months.

The official record: Incyte’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Incyte's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Incyte's return on equity?
Incyte (INCY) reported return on equity of 30.8% in Q1 2026.
How has Incyte's return on equity changed year-over-year?
Incyte's return on equity increased by 6466.4% year-over-year, from 0.5% to 30.8%.
What is the long-term trend for Incyte's return on equity?
Over 4 years (2021 to 2025), Incyte's return on equity has grown at a 0.8% compound annual growth rate (CAGR), from 82.3% to 85%.
What does return on equity mean?
How much profit the company earns on the money shareholders have invested.
How do you interpret return on equity?
Higher is better, but very high ROE can be manufactured by leverage — a thin equity base inflates the ratio. Read it next to debt-to-equity and ROIC to tell genuine returns from balance-sheet engineering.
How does return on equity compare across companies?
Comparable across peers, with the leverage caveat. Negative or near-zero equity makes ROE meaningless, so it is suppressed there.